BHC (Bausch Health) Other Long-Term Liabilities: $943 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHC Bausch Health Companies Inc BHC
64 GF Score
Price $6.89
GF Value $7.73
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Bausch Health Other Long-Term Liabilities?

Bausch Health BHC +14.26% 64 Other Long-Term Liabilities is $943 Mil as of Jun. 2026. GuruFocus rates BHC with a GF Score™ of 64/100 and a GF Value™ of $7.73 (Fairly Valued). The stock has 3 warning signs investors should review.

Bausch Health's other long-term liabilities for the quarter that ended in Jun. 2026 was $943 Mil.

Bausch Health's quarterly other long-term liabilities declined from Dec. 2025 ($1,047 Mil) to Mar. 2026 ($976 Mil) and declined from Mar. 2026 ($976 Mil) to Jun. 2026 ($943 Mil).

Bausch Health's annual other long-term liabilities declined from Dec. 2023 ($1,029 Mil) to Dec. 2024 ($1,023 Mil) but then increased from Dec. 2024 ($1,023 Mil) to Dec. 2025 ($1,047 Mil).

Bausch Health Other Long-Term Liabilities Related Terms

Bausch Health Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Bausch Health's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Other Long-Term Liabilities Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 855.00 949.00 1,029.00 1,023.00 1,047.00

Bausch Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,141.00 1,067.00 1,047.00 976.00 943.00
BHC
64GF Score
Bausch Health Companies Inc BHC
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $943 Mil mean?
Bausch Health (BHC) has a Other Long-Term Liabilities of $943 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bausch Health and its competitors.
Is Bausch Health's Other Long-Term Liabilities too high?
Bausch Health's current Other Long-Term Liabilities is $943 Mil. Overall, Bausch Health has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Other Long-Term Liabilities compare to ZTS?
Bausch Health's Other Long-Term Liabilities of $943 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bausch Health and its competitors. Bausch Health's current Other Long-Term Liabilities is $943 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Fairly Valued. The stock's GF Value™ is $7.73, compared to a current price of $6.89 — trading 10.9% below its estimated fair value. The current Other Long-Term Liabilities is $943 Mil. Bausch Health's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Bausch Health (BHC), the current Other Long-Term Liabilities is $943 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $6.89 is trading 10.9% below its estimated GF Value™ of $7.73. GuruFocus considers Bausch Health to be Fairly Valued.

Key valuation signals for BHC:

  • Other Long-Term Liabilities: $943 Mil
  • GF Value™: $7.73 vs. price of $6.89 (10.9% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
64GF Score

Get the complete analysis for BHC

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.89
Price
$7.73
GF Value